Morgan Joseph commented on Dendreon (Nasdaq: DNDN) after the CMS has decided to commission an external assessment of Provenge.

This article: 154 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE